05/14/2024 4:14 PM | Eterna Therapeutics Inc. (Filer) Eterna Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
03/22/2024 3:30 PM | Eterna Therapeutics Inc. (Filer) Eterna Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/18/2024 6:30 AM | Eterna Therapeutics Inc. (Filer) Eterna Therapeutics (Filer)
| Form 10-K/A | |
02/16/2024 4:30 PM | Cicala Peter (Reporting) Eterna Therapeutics Inc. (Issuer) Eterna Therapeutics (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
02/16/2024 6:30 AM | Eterna Therapeutics Inc. (Filer) Eterna Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/31/2024 6:05 AM | Eterna Therapeutics Inc. (Subject) Eterna Therapeutics (Subject) HALPERN JOHN D (Filed by)
| Form SC 13G/A | |
01/22/2024 11:15 PM | Eterna Therapeutics Inc. (Filer) Eterna Therapeutics (Filer)
| Form EFFECT | |
|
01/19/2024 9:31 AM | Eterna Therapeutics Inc. (Subject) Eterna Therapeutics (Subject) Singer Nicholas Jason (Filed by)
| Form SC 13G/A | |
01/12/2024 3:49 PM | Eterna Therapeutics Inc. (Filer) Eterna Therapeutics (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
12/22/2023 11:05 AM | Cherington Charles (Filed by) Eterna Therapeutics Inc. (Subject) Eterna Therapeutics (Subject)
| Form SC 13D/A | |
12/20/2023 3:20 PM | Eterna Therapeutics Inc. (Filer) Eterna Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/20/2023 2:24 PM | Eterna Therapeutics Inc. (Subject) Eterna Therapeutics (Subject) IAF, LLC (Filed by)
| Form SC 13G | |
12/20/2023 9:05 AM | Cherington Charles (Reporting) Eterna Therapeutics Inc. (Issuer) Eterna Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/18/2023 8:38 PM | Eterna Therapeutics Inc. (Issuer) Eterna Therapeutics (Issuer) Freebird Investments LLC (Reporting) Freebird Partners LP (Reporting) HUFF CURTIS W (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/14/2023 3:30 PM | Eterna Therapeutics Inc. (Filer) Eterna Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/13/2023 4:30 PM | Bristol James Arthur (Reporting) Eterna Therapeutics Inc. (Issuer) Eterna Therapeutics (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
11/13/2023 7:30 AM | Eterna Therapeutics Inc. (Filer) Eterna Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/01/2023 7:34 AM | Eterna Therapeutics Inc. (Filer) Eterna Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/05/2023 3:30 PM | Eterna Therapeutics Inc. (Filer) Eterna Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/26/2023 3:30 PM | Eterna Therapeutics Inc. (Filer) Eterna Therapeutics (Filer)
| Form 8-K/A | |
09/08/2023 5:07 AM | Eterna Therapeutics Inc. (Subject) Eterna Therapeutics (Subject) Singer Nicholas Jason (Filed by)
| Form SC 13G/A | |
09/07/2023 4:26 PM | Cherington Charles (Filed by) Eterna Therapeutics Inc. (Subject) Eterna Therapeutics (Subject)
| Form SC 13D/A | |
09/01/2023 4:00 PM | Clarke Dorothy J (Reporting) Eterna Therapeutics Inc. (Issuer) Eterna Therapeutics (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
08/28/2023 3:57 PM | Eterna Therapeutics Inc. (Subject) Eterna Therapeutics (Subject) Purchase Capital LLC (Filed by)
| Form SC 13G | |
08/25/2023 6:34 PM | Cherington Charles (Reporting) Eterna Therapeutics Inc. (Issuer) Eterna Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/23/2023 6:00 AM | Eterna Therapeutics Inc. (Filer) Eterna Therapeutics (Filer)
| Form 424B3 | |
08/22/2023 11:15 PM | Eterna Therapeutics Inc. (Filer) Eterna Therapeutics (Filer)
| Form EFFECT | |
08/02/2023 4:25 PM | Eterna Therapeutics Inc. (Filer) Eterna Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/18/2023 3:15 PM | Eterna Therapeutics Inc. (Issuer) Eterna Therapeutics (Issuer) WAGNER RICHARD W (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/18/2023 3:15 PM | BINDER BRANT (Reporting) Eterna Therapeutics Inc. (Issuer) Eterna Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/18/2023 7:05 AM | Eterna Therapeutics Inc. (Filer) Eterna Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/18/2023 5:10 AM | Eterna Therapeutics Inc. (Issuer) Eterna Therapeutics (Issuer) Freebird Investments LLC (Reporting) Freebird Partners LP (Reporting) HUFF CURTIS W (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/13/2023 5:02 AM | Eterna Therapeutics Inc. (Filer) Eterna Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/11/2023 3:30 PM | BINDER BRANT (Reporting) Eterna Therapeutics Inc. (Issuer) Eterna Therapeutics (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
07/11/2023 3:31 PM | Eterna Therapeutics Inc. (Issuer) Eterna Therapeutics (Issuer) WAGNER RICHARD W (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
07/11/2023 3:15 PM | Eterna Therapeutics Inc. (Filer) Eterna Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/23/2023 7:30 PM | Eterna Therapeutics Inc. (Issuer) Eterna Therapeutics (Issuer) Gurrola Sandra M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/20/2023 3:32 PM | Eterna Therapeutics Inc. (Filer) Eterna Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |